Abstract
Seizure susceptibility and GABA metabolism were altered in the substantia nigra [SN] of adult male Sprague Dawley rats when these animals were acclimating to an altered plasma osmolality. Changes in GABA metabolism were measured in vivo in SN of the freely moving rat. Suitable precautions were taken to avoid any post-mortem flux of glutamate to GABA and to correct for the underestimation of GABA build up in SN due to the finite diffusion rate of γ-vinyl GABA [GVG] after stereotaxic injection of small amounts into one side of the brain. Control experiments provided evidence that changes in osmolality, within a normal physiological range, did not affect significantly γ-aminobutyric acid transaminase [GABA-T]. Also kindling via the medial septum [MS], in the absence of electrical stimulation did not alter GABA metabolism in SN, thus providing a stable baseline for studies of osmotic effects. Hyperosmolality was associated with a rise in seizure thresholds, with a marked reduction of the rate of GABA synthesis in SN, and with a substantial increase in turnover time of the GABA pool. Hypoosmolality, of a degree known to be associated with mild cerebral edema and swelling localized to astrocytes, markedly reduced seizure threshold, and reduced GABA pool size in SN, but did not alter the rate of GABA synthesis significantly. These results demonstrate by new and independent means the relationship between GABA metabolism in the SN and seizure susceptibility in vivo.
Similar content being viewed by others
References
Rowntree, L. G. 1926. The effects on mammals of the administration of excessive quantities of water. J. Pharmacol. Therap. 29:135–159.
Garland, H. G., Dick, A. P., and Whitty, C. W. M. 1943. Waterpitressin test in the diagnosis of epilepsy. Lancet 2:566–569.
Carter, C. H. 1962. Status epilepticus treated by intravenous urea. Epilepsia 3:198–200.
Baran, H., Lassmann, H., Sperk, G., Seitelberger, F., and Hornykiewicz, O. 1987. Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neuroscience 21:679–684.
Fishman, R. A. 1974. Cell volume, pumps and neurologic function: brain's adaptation to osmotic stress. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 53:159–172.
Reed, D. J. and Woodbury, D. M. 1964. The effect of hypertonic urea solution on electroshock seizure threshold and electrolyte distribution in rats. J. Pharmacol. 146:154–159.
Cserr, H. F., DePasquale, M., and Patlak, C. S. 1987. Regulation of brain water and electrolytes during acute hyperosmolality in rats. Am. J. Physiol. 253:F522-F529.
Hoffman, E. K., and Simonsen, L. O. 1989. Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol. Rev. 69:315–377.
Wasterlain, C. G., and Posner, J. B. 1969. Cerebral edema in water intoxication. Arch. Neurol. 19:71–78.
Baxter, C. F., Wasterlain, C. G., Hallden, K. L., and Pruess, S. F. 1986. Effect of altered blood plasma osmolalities on regional brain amino acid concentrations and focal seizure susceptibility in the rat. J. Neurochem. 47:617–624.
Medani, C. R. 1987. Seizures and hypothermia due to dietary water intoxication in infants. South. Med. J. 80:421–425.
Andrew, R. D. 1990. Seizure and acute osmotic change: clinical and neurophysiological aspects. J. Neurol. Sci. in press.
Andrew, R. D., Fagen, M., Bailyk, B. A., and Rosen, A. S. 1989. Seizure susceptibility and the osmotic state. Brain Res. 498:175–180.
Kamphuis, W., Wadman, W. T., Buijs, R. M., and Lopes da Silva, F. H. 1987. The development of change in hippocampal GABA immunoreactivity in the rat kindling model of epilepsy: a light microscopic study with GABA antibodies. Neuroscience 23:433–446.
Löscher, W., and Schwark, W. S. 1985. Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats. Brain Res. 339:146–150.
Roberts, E., Chase, T. N., and Tower, D. B. (eds.) 1976. GABA in Nervous System Function. 554 pages. Raven Press, New York.
Littauer, U. Z., Dudai, Y., Silman, I., Teichberg, V. I., and Vogel, Z. (eds.) 1980. Neurotransmitters and Their Receptors. 570 pages. John Wiley and Sons, New York.
Lal, H., Fielding, S., Malick, J., Roberts, E., Shah, N., and Usdin, E. (eds.) 1980. GABA Neurotransmission: Current Development in Physiology and Neurochemistry. Vol. 5. Supplement 2. 946 pages. Ankho International Inc. Fayetteville, New York.
Gaspar, P., Javoy-Agid, F., Ploska, A., and Agid, F. 1980. Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain. J. Neurochem. 34:278–283.
Kuriyama, K. 1976. Subcellular localization of the GABA system in brain. Pages 187–196,in Roberts, E., Chase, T. N., and Tower, D. B. (eds.). Kroc. Fdn. Series 5, Raven Press, New York.
Asakura, T., Ikeda, T. and Matsuda, M. 1989. Distribution of activity converting 4-aminobutyraldehyde to γ-aminobutyric acid in subcellular fractions of mouse brain. J. Neurochem. 52:448–452.
Wood, J. D. 1981. Evaluation of a synaptosomal model for monitoring in vivo changes in the GABA and glutamate content of nerve endings. Internat. J. Biochem. 13:543–548.
Iadarola, M.J., and Gale, K. 1980. Evaluation of increases in nerve terminal-dependent vs nerve terminal-independent compartments of GABA in vivo. Brain Res. Bull. 5 suppl. 2:13–19.
Olsen, R. W., and Tobin, A. J. 1990. Molecular biology of GABA receptors. FASEB J. 4:1469–1480.
Ribak, C. E., Joubran, C., Kesslak, J. P., and Bakay, R. A. E. 1989. A selective decrease in the number of GABAergic somata occurs in pre-seizing monkeys with alumina gel granuloma. Epilepsy Res. 4:126–130.
Houser, C. R. 1991. GABA neurons in seizure disorders: A review of cytochemical studies. Neurochem. Res. 16:295–308.
Guastella, J., Nelson, N., Nelson, H. Czyzyk, L., Keynan, S., Miedel, M. C., Davidson, N., Lester, H. A., and Kanner, B. I. 1990. Cloning and expression of a rat brain GABA transporter. Science 249:1303–1306.
Nicholls, D. G. 1989. Release of glutamate, aspartate, and γ-aminobutyric acid from isolated nerve terminals. J. Neurochem. 52:331–341.
Green, A. R., Minchin, C. G., and Vincent, N. D. 1987. Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion. Brt. J. Pharm. 92:13–18.
Hille, B. (ed.) 1984. Ionic Channels of Excitable Membranes. 424 pages. Sinauer Assoc. Mass.
Wafford, K. A., Sattelle, D. B., Abalis, I., Eldefrawi, A. T., and Eldefrawi, M. E. 1987. γ-amino butyric acid-activated36Cl-influx: a functional in vitro assay for CNS γ-aminobutyric acid receptors of insects. J. Neurochem. 48:177–180.
Engle, J. Jr., Wolfson, L., and Brown, L. 1978. Anatommical correlates of electrical and behavioral events related to amygdaloid kindling. Ann. Neurol. 3:538–544.
Iadarola, M. J., and Gale, K. 1982. Substantia nigra: site of anticonvulsant activity mediated by γ-aminobutyric acid. Sci. 218:1237–1240.
Watford, M. 1990. A “swell” way to regulate metabolism. TIBS. 15:329–330.
Baxter, C. F., Kodama, C. K., Baldwin, R. A., and Pruess, S. 1987. Osmolality and glycogen metabolism: Effect on brain and liver. J. Neurochem. 48:94.
Baxter, C. F. 1986. The effect of altered osmolalities upon putative neurotransmitter amino acids in the central nervous system: Biochemical mechanisms with some physiological and behavioral correlates. Bull. Tokyo Met. Inst. for Neurosci. 15 suppl. 2:83–99.
Pasantes-Morales, H., and Schousboe, A. 1988. Volume regulation in astrocytes: A role for taurine as an osmoeffector. J. Neurosci. Res. 20:505–509.
Baxter, C. F., Baldwin, R. A., and Oh, C. C. 1990. Acclimation to hyper and hypo-osmotic changes: the anomalous behavior of taurine in the nervous system and in the blood of vertebrates. Pages 329–336,in Pasantes-Morales, H., Martin, D. L., Shain, W., and Martin del Rio, R. (eds.), Taurine: Functional Neurochemistry, Physiology, and Cardiology, Wiley-Liss Inc., New York.
Kulakowski, E. C., Maturo, J., and Schaffer, S. W. 1985. The low affinity taurine binding protein may be related to the insulin receptor. Pages 127–136,in Oja S. S., Antee, L., Kontro, P., and Paasonen, M. K. (eds), Taurine: Biological actions and clinical perspectives, Alan R. Liss, New York.
Maturo, J. M., and Kulakowski, E. C. 1988. Taurine binding to the purified insulin receptor. Biochem. Pharmacol. 33:3755–3760.
Paxinos, G., and Watson, C. 1986. The Rat Brain in Sterotaxic Coordinates, Second edition, Academic Press, New York.
Casu, M., and Gale, K. 1981. Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo. Life Sci. 29:681–688.
Wasterlain, C. G., and Farber, D. B. 1982. A lasting change in protein phosphorylation associated with septal kindling. Brain Res. 247:191–194.
Racine, R. J. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:281–294.
Racine, R. J., 1978. Kindling: the first decade. J. Neurosurg. 3:234–252.
Gale, K. 1984. Binding of [3H] gamma-vinyl-GABA to GABA transaminase in brain homogenates. Life Sci. 34:701–706.
Gale, K., Sarvey, C., Stork, J., Childs, G. A., Yalisovc, B. L., and Dayhoff, R. E. 1984. Quantitative histochemical measurement of GABA transminase: method for evaluation of intracerebral lesions produced by excitotoxic agents. Brain Res. 307:255–262.
Karlsson, A., Fonnum, F., Malthe-Sorenssen, D., and Storm-Mathisen, J. 1974. Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids, and glutamate decarboxylase in different regions of the rat brain. Biochem. Pharm. 23:3053–3061.
Van der Heyden, J. A. M., and Korf, J. 1978. Regional levels of GABA in the brain: Rapid semiautomated assay and prevention of postmortem increase by 3-mercapto-propionic acid. J. Neurochem. 31:197–203.
Minard, F. N., and Mushahwar, I. K. 1966. Synthesis of γ-aminobutyric acid from a pool of glutamic acid in brain after decapitation. Life Sci. 5:1409–1413.
Van der Heyden, J. A. M., deKloet, E. R., Korf, J., and Versteeg, D. H. G. 1979. GABA content of discrete brain nuclei and spinal cord of the rat. J. Neurochem. 33:857–861.
Baxter, C. F., Parsons, J. E., Oh, C. C., Wasterlain, C. G., and Baldwin, R. A. 1989. Changes of amino acid gradients in brain tissue induced by microwave irradiation and other means. Neurochem. Res. 14:909–913.
Giorgi, O., and Meek, J. L. 1984. γ-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid. J. Neurochem. 42:215–220.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M. Olson, B. J., and Klenk, D. C. 1985. Measurement of protein using bicinchoninic acid. Analyt. Biochem. 150:76–85.
Baxter, C. F., and Baldwin, R. A. 1978. A functional role for amino acids in the adaptation of tissue from the nervous system to alterations in environmental osmolality. Pages 599–627,in Fonnum, F. (ed.), Amino Acids as Chemical Transmitters, Plenum Press, New York.
Jones, B. N., and Gilligan, J. P. 1983. O-pthaladehyde precolumn derivation and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J. Chromatog. 266:471–482.
Tachiki, K. H. and Baxter, C. F. 1979. Taurine levels in brain tissues: a need for reevaluation. J. Neurochem. 33:1125–1129.
Jarrett, H. W., Cooksy, K. D. Ellis, B., and Anderson, J. M. 1986. The separation of O-pthaladehyde derivatives of amino acids by reversed-phase chromatography of octylsilica columns. Analyt. Biochem. 153:189–198.
Cubells, J. F., Blanchard, J. S., Smith, D. M., and Makman, M. H. 1986.In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and γ-aminobutyric acid transaminase in retina vs brain. J. Pharmacol. Exptl. Therap. 238:508–514.
Traynelis, S. F., and Dingledine, R. 1989. Role of hyperosmotic space in hyperosmotic suppression of potassium-induced electrographic seizures. J. Neurophysiol. 61:927–940.
Paulsen, R. E., and Fonnum, F. 1988. Regulation of transmitter γ-aminobutyric acid (GABA) synthesis and metabolism illustrated by the effect of γ-vinyl GABA and hypoglycemia. J. Neurochem. 50:1151–1157.
Jung, M. J., Lippert, B. Metalf, B. W., Bohlen, P., and Schechter, P. J. 1977. γ-vinyl-GABA, a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J. Neurochem. 29:797–802.
Baxter, C. F., Oh, C. C., and Wasterlain, C. G. 1990. Effect of electrical stimulation on GABA metabolism in substantia nigra [SN] and hippocampus [HC] of kindled rats. Epilepsia 31:631.
Garant, D. S., and Gale, K. 1987. Substantia nigra mediated anticonvulsant actions: role of nigral output pathways. Experimental Neurology. 97:143–159.
Baxter, C. F., Oh, C. C., and Ozaki, L. K. 1990. GABA turnover in substantia nigra: effects of altered plasma osmolalities. Proc. Am. Soc. Neurochem. p161. Phoenix Arizona.
Arieff, A. I., Guisado, R., and Lazarowitz, V. C. 1977. Pathophysiology of hyperosmolal states. Pages 227–250,in Andreoli, T. E., Graham, J. J., and Rector, F. C. (eds.), Disturbances in Body Fluid Osmolality Am. Physiol. Soc. Publication, Williams and Wilkins Co., Baltimore, MD.
Vastola, E. G., Maccario, M., and Homan, R. 1967. Activation of epileptogenic foci by hyperosmolality. Neurology 17:520–526.
Green, A. R., Metz, A., Minchin, C. W., and Vincent, N. D. 1987. Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion. Brit. J. Pharmacol. 92:5–11.
Balcon, G. J., Lenox, R. H., and Meyerhoff, J. L. 1975. Regional γ-aminobutyric acid levels in rat brain determined after microwave fixation. J. Neurochem. 24:609–613.
Ciesielski, L., Simler, S., Clement, J., and Mandel, P. 1987. Effect of repeated convulsive seizures on brain γ-aminobutyric acid metabolism in three sublines of mice differing by their responsed to acoustic stimulation. J. Neurochem. 49:220–226.
Liu, D. D., Ueno, E., Ho, I. K., and Hoskins, B. 1988. Evidence that alterations in γ-aminobutyric acid and acetylcholine in rat striata and cerebella are not related to soman-induced convulsions. J. Neurochem. 51:181–187.
Seiler, N., and Sarhan, S. 1984. Synergistic anticonvulsant effects of GABA-T inhibitors and glycine. Naunyn-Schmiedlberg's Arch. Pharmacol. 326:9–57.
Liu, Z., Seiler, N., Marescaux, C., Depaulis, A., and Vergnes, M. 1990. Potentiation of γ-vinyl GABA (Vigabatrin) effects by glycine. Europ. J. Pharmacol. 182:109–115.
Sarhan, S. Casara, P., Knodgen, B., and Seiler, N. 1990. (4S)-4 amino-5,6 Heptadienoic acid (MDL72483): A potent anticonvulsant GABA-T inhibitor. Neurochem. Res. this volume.
Mao, C. C., and Costa, E. 1978. Biochemical pharmacology of GABA transmission. Pages 307–318,in Lipton, M. A., Dimascio, A., and Killam, K. F. (eds.), Psychopharmacology: A Generation of Progress, Raven Press, New York.
Gale, K. 1982. Evidence for GABA receptors on serotonergic afferent terminals in the substantia nigra efferent projections to the caudal mesencephelon. Brain Res. 231:209–215.
Ribak, C. E. 1983. Morphological, biochemical and immunocytochemical changes of the cortical GABAergic system in epileptic foci. Pages 110–130,in Ward, A. A. Jr., Perry, J. K., and Purpura, D. (eds.), Raven Press, New York.
Kamphuis, W., Wadman, W. J., Buijs, R. M., and Lopes da Silva, F. H. 1988. Decrease in number of hippocampal gamma-aminobutyric acid (GABA) immunoreactive cells in the rat kindling model of epilepsy. Exp. Brain Res. 64:91–495.
Ribak, C. E., Harris, A. B., Vaughn, J. E., and Roberts, E. 1979. Inhibitory GABAergic nerve terminals decrease at sites of focal epilepsy. Science 205:211–214.
Brailowsky, S., Kunimoto, M., Menini, C., Silva Barrat, C., Riche, D., and Naquet, R. 1988. The GABA-withdrawal syndrome: A new model of focal epileptogenesis. Brain Res. 442:175–179.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Eugene Roberts.
Rights and permissions
About this article
Cite this article
Baxter, C.F., Oh, C.C., Wasterlain, C.G. et al. Alterations of GABA metabolism and seizure susceptibility in the substantia nigra of the kindled rat acclimating to changes in osmotic state. Neurochem Res 16, 269–278 (1991). https://doi.org/10.1007/BF00966090
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00966090